Corneal Allografts: Factors for and against Acceptance

Cornea is one of the most commonly transplanted tissues worldwide. However, it is usually omitted in the field of transplantology. Transplantation of the cornea is performed to treat many ocular diseases. It restores eyesight significantly improving the quality of life. Advancements in banking of ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Justyna Sakowska, Paulina Glasner, Maciej Zieliński, Piotr Trzonkowski, Leopold Glasner
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/5372090
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172803168337920
author Justyna Sakowska
Paulina Glasner
Maciej Zieliński
Piotr Trzonkowski
Leopold Glasner
author_facet Justyna Sakowska
Paulina Glasner
Maciej Zieliński
Piotr Trzonkowski
Leopold Glasner
author_sort Justyna Sakowska
collection DOAJ
description Cornea is one of the most commonly transplanted tissues worldwide. However, it is usually omitted in the field of transplantology. Transplantation of the cornea is performed to treat many ocular diseases. It restores eyesight significantly improving the quality of life. Advancements in banking of explanted corneas and progressive surgical techniques increased availability and outcomes of transplantation. Despite the vast growth in the field of transplantation laboratory testing, standards for corneal transplantation still do not include HLA typing or alloantibody detection. This standard practice is based on immune privilege dogma that accounts for high success rates of corneal transplantation. However, the increasing need for retransplantation in high-risk patients with markedly higher risk of rejection causes ophthalmology transplantation centers to reevaluate their standard algorithms. In this review we discuss immune privilege mechanisms influencing the allograft acceptance and factors disrupting the natural immunosuppressive environment of the eye. Current developments in testing and immunosuppressive treatments (including cell therapies), when applied in corneal transplantation, may give very good results, decrease the possibility of rejection, and reduce the need for retransplantation, which is fairly frequent nowadays.
format Article
id doaj-art-cc2a026e166340e5ba54d7a5437888e8
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-cc2a026e166340e5ba54d7a5437888e82025-08-20T02:19:58ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/53720905372090Corneal Allografts: Factors for and against AcceptanceJustyna Sakowska0Paulina Glasner1Maciej Zieliński2Piotr Trzonkowski3Leopold Glasner4Department of Medical Immunology, Medical University of Gdańsk, Dębinki 7 Street, Building 27, 80-211 Gdańsk, PolandDepartment of Anaesthesiology and Intensive Care, Medical University of Gdańsk, Mariana Smoluchowskiego 17 Street, 80-214 Gdańsk, PolandDepartment of Medical Immunology, Medical University of Gdańsk, Dębinki 7 Street, Building 27, 80-211 Gdańsk, PolandDepartment of Medical Immunology, Medical University of Gdańsk, Dębinki 7 Street, Building 27, 80-211 Gdańsk, PolandDepartment of Ophthalmology, Medical University of Gdańsk, Mariana Smoluchowskiego 17 Street, 80-214 Gdańsk, PolandCornea is one of the most commonly transplanted tissues worldwide. However, it is usually omitted in the field of transplantology. Transplantation of the cornea is performed to treat many ocular diseases. It restores eyesight significantly improving the quality of life. Advancements in banking of explanted corneas and progressive surgical techniques increased availability and outcomes of transplantation. Despite the vast growth in the field of transplantation laboratory testing, standards for corneal transplantation still do not include HLA typing or alloantibody detection. This standard practice is based on immune privilege dogma that accounts for high success rates of corneal transplantation. However, the increasing need for retransplantation in high-risk patients with markedly higher risk of rejection causes ophthalmology transplantation centers to reevaluate their standard algorithms. In this review we discuss immune privilege mechanisms influencing the allograft acceptance and factors disrupting the natural immunosuppressive environment of the eye. Current developments in testing and immunosuppressive treatments (including cell therapies), when applied in corneal transplantation, may give very good results, decrease the possibility of rejection, and reduce the need for retransplantation, which is fairly frequent nowadays.http://dx.doi.org/10.1155/2021/5372090
spellingShingle Justyna Sakowska
Paulina Glasner
Maciej Zieliński
Piotr Trzonkowski
Leopold Glasner
Corneal Allografts: Factors for and against Acceptance
Journal of Immunology Research
title Corneal Allografts: Factors for and against Acceptance
title_full Corneal Allografts: Factors for and against Acceptance
title_fullStr Corneal Allografts: Factors for and against Acceptance
title_full_unstemmed Corneal Allografts: Factors for and against Acceptance
title_short Corneal Allografts: Factors for and against Acceptance
title_sort corneal allografts factors for and against acceptance
url http://dx.doi.org/10.1155/2021/5372090
work_keys_str_mv AT justynasakowska cornealallograftsfactorsforandagainstacceptance
AT paulinaglasner cornealallograftsfactorsforandagainstacceptance
AT maciejzielinski cornealallograftsfactorsforandagainstacceptance
AT piotrtrzonkowski cornealallograftsfactorsforandagainstacceptance
AT leopoldglasner cornealallograftsfactorsforandagainstacceptance